The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
A network dysfunction perspective on neurodegenerative diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
What is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Self-citationAPP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Memory and Executive Function in Aging and AD
Buckner, R. L. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.006 · Cited by 1,508
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Degeneracy and complexity in biological systems
Edelman, G. M., & Gally, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231499798 · Cited by 1,493
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Molecular profile of reactive astrocytes—Implications for their role in neurologic disease
Eddleston, M., & Mucke, L. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90380-x · Cited by 1,431
Self-citationLife and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235
Self-citationDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · cited 1×
“Notably, the abnormal proteins that are suspected of causing neurodegenerative disorders impair the integrity or function of presynaptic terminals and postsynaptic specialization”
BackgroundPlaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Self-citationSimilar network activity from disparate circuit parameters
Prinz, A. A., Bucher, D., & Marder, E. (2004) · Nature Neuroscience · doi:10.1038/nn1352 · Cited by 1,091 · cited 1×
“Even in the absence of disease, neural systems are characterized by extensive 'degeneracy' — in other words, the ability of structurally different elements to perform the same function or yield the same outpu”
BackgroundReversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease
Yamamoto, A., Lucas, J. J., & Hen, R. (2000) · Cell · doi:10.1016/s0092-8674(00)80623-6 · Cited by 1,067
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024
Mitochondria take center stage in aging and neurodegeneration
Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20624 · Cited by 957
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease
HYND, M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.007 · Cited by 938
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD
Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., Bertram, L., Mullin, K., Tanzi, R. E., Blacker, D., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000171450.97464.49 · Cited by 910
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
Lazarov, O., Robinson, J., Tang, Y.-P., Hairston, I. S., Korade-Mirnics, Z., Lee, V. M.-Y., Hersh, L. B., Sapolsky, R. M., Mirnics, K., & Sisodia, S. S. (2005) · Cell · doi:10.1016/j.cell.2005.01.015 · Cited by 885
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn842 · Cited by 858
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 818
Iaria, G., Petrides, M., Dagher, A., Pike, B., & Bohbot, V. D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05945.2003 · Cited by 799
Neurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
Self-citationDuncan, J. S., Sander, J. W., Sisodiya, S. M., & Walker, M. C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68477-8 · Cited by 728
Nervous system reorganization following injury
Chen, R., Cohen, L. G., & Hallett, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00025-8 · Cited by 724
DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., & Mufson, E. J. (2002) · Annals of Neurology · doi:10.1002/ana.10069 · Cited by 686 · cited 1×
“For example, choline-acetyltransferase activity in the hippocampus is increased in mild cognitive impairment (MCI), which may precede or represent early AD, but is decreased in later stages of the diseas”
BackgroundNeuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease
Price, J. L., Ko, A. I., Wade, M. J., Tsou, S. K., McKeel, D. W., & Morris, J. C. (2001) · Archives of Neurology · doi:10.1001/archneur.58.9.1395 · Cited by 596
Incidence and Predictors of Seizures in Patients with Alzheimer's Disease
Amatniek, J. C., Hauser, W. A., DelCastillo‐Castaneda, C., Jacobs, D. M., Marder, K., Bell, K., Albert, M., Brandt, J., & Stern, Y. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00554.x · Cited by 590
Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease
Masliah, E., Rockenstein, E., Adame, A., Alford, M., Crews, L., Hashimoto, M., Seubert, P., Lee, M., Goldstein, J., Chilcote, T., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.010 · Cited by 542
Evidence from Functional Neuroimaging of a Compensatory Prefrontal Network in Alzheimer's Disease
Grady, C. L., McIntosh, A. R., Beig, S., Keightley, M. L., Burian, H., & Black, S. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00986.2003 · Cited by 504
Neuroplasticity Failure in Alzheimer's Disease
Mesulam, M.-M. (1999) · Neuron · doi:10.1016/s0896-6273(00)81109-5 · Cited by 449
Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437
Reversible memory loss in a mouse transgenic model of Alzheimer’s disease
Kotilinek, L. A., Bacskai, B., Westerman, M., Kawarabayashi, T., Younkin, L., Hyman, B. T., Younkin, S., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06331.2002 · Cited by 420
Palop, J. J., Jones, B., Kekonius, L., Chin, J., Yu, G.-Q., Raber, J., Masliah, E., & Mucke, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133381100 · Cited by 402 · cited 1×
“The radiological, electrophysiological and molecular mapping of neuronal activities across brain regions is beginning to define the functional topology of neurodegenerative disorders, which extends well beyond the areas showing typical pathological alteration”
BackgroundSelf-citationBeta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses
Almeida, C. G., Tampellini, D., Takahashi, R. H., Greengard, P., Lin, M. T., Snyder, E. M., & Gouras, G. K. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.008 · Cited by 397
Alzheimer's disease and Aβ toxicity: from top to bottom
Small, D. H., Mok, S. S., & Bornstein, J. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086072 · Cited by 394
Walker, M. P., Ayre, G. A., Cummings, J. L., Wesnes, K., McKeith, I. G., O'Brien, J. T., & Ballard, C. G. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.252 · Cited by 362
Greffard, S., Verny, M., Bonnet, A.-M., Beinis, J.-Y., Gallinari, C., Meaume, S., Piette, F., Hauw, J.-J., & Duyckaerts, C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.584 · Cited by 354
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated
Bezard, E., Gross, C. E., & Brotchie, J. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00038-9 · Cited by 350
Current Pharmacotherapy for Alzheimer's Disease
Lleó, A., Greenberg, S. M., & Growdon, J. H. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131442 · Cited by 345
Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C., & Muchowski, P. J. (2005) · Nature Genetics · doi:10.1038/ng1542 · Cited by 328
Chin, J., Palop, J. J., Puoliväli, J., Massaro, C., Bien-Ly, N., Gerstein, H., Scearce-Levie, K., Masliah, E., & Mucke, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2980-05.2005 · Cited by 312
Self-citationMortality of Epilepsy in Developed Countries: A Review
Forsgren, L., Hauser, W. A., Olafsson, E., Sander, J. W. A. S., Sillanpää, M., & Tomson, T. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00403.x · Cited by 282
Roselli, F., Tirard, M., Lu, J., Hutzler, P., Lamberti, P., Livrea, P., Morabito, M., & Almeida, O. F. X. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3034-05.2005 · Cited by 277
Quantifying fluctuation in dementia with Lewy bodies, Alzheimer’s disease, and vascular dementia
Walker, M. P., Ayre, G. A., Cummings, J. L., Wesnes, K., McKeith, I. G., O’Brien, J. T., & Ballard, C. G. (2000) · Neurology · doi:10.1212/wnl.54.8.1616 · Cited by 269
Verdier, Y., Zarándi, M., & Penke, B. (2004) · Journal of Peptide Science · doi:10.1002/psc.573 · Cited by 262
Routes to remembering: the brains behind superior memory
Maguire, E. A., Valentine, E. R., Wilding, J. M., & Kapur, N. (2003) · Nature Neuroscience · doi:10.1038/nn988 · Cited by 253
Dendrite and dendritic spine alterations in alzheimer models
Moolman, D. L., Vitolo, O. V., Vonsattel, J.-P. G., & Shelanski, M. L. (2004) · Journal of Neurocytology · doi:10.1023/b:neur.0000044197.83514.64 · Cited by 245
Dickey, C. A., Loring, J. F., Montgomery, J., Gordon, M. N., Eastman, P. S., & Morgan, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05219.2003 · Cited by 242
Cognitive Decline in Severe Intractable Epilepsy
Thompson, P. J., & Duncan, J. S. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00279.x · Cited by 240
Watanabe, D., Inokawa, H., Hashimoto, K., Suzuki, N., Kano, M., Shigemoto, R., Hirano, T., Toyama, K., Kaneko, S., Yokoi, M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81779-1 · Cited by 224
Tau alteration and neuronal degeneration in tauopathies: mechanisms and models
Brandt, R., Hundelt, M., & Shahani, N. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.018 · Cited by 221
Juvenile onset Huntington's disease—clinical and research perspectives
Nance, M. A., & Myers, R. H. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1022 · Cited by 185
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect
Levine, M. S., Cepeda, C., Hickey, M. A., Fleming, S. M., & Chesselet, M.-F. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.008 · Cited by 183
Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer's disease
Kobayashi, D. T., & Chen, K. S. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00124.x · Cited by 175
Martı́n-Aparicio, E., Yamamoto, A., Hernández, F., Hen, R., Avila, J., & Lucas, J. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08772.2001 · Cited by 171
Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct
Bradshaw, J. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2002.002576 · Cited by 169
Septal networks: relevance to theta rhythm, epilepsy and Alzheimer's disease
Colom, L. V. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03630.x · Cited by 164
Present and future drug treatment for Parkinson's disease
Schapira, A. H. V. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.035980 · Cited by 163
Plasticity of the nigropallidal pathway in Parkinson's disease
Whone, A. L., Moore, R. Y., Piccini, P. P., & Brooks, D. J. (2003) · Annals of Neurology · doi:10.1002/ana.10427 · Cited by 162
Palop, J. J., Chin, J., Bien‐Ly, N., Massaro, C. M., Yeung, B. Z., Yu, G.-Q., & Mucke, L. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2829-05.2005 · Cited by 161
Self-citationAlzheimer's patients engage an alternative network during a memory task
Pariente, J., Cole, S., Henson, R., Clare, L., Kennedy, A., Rossor, M., Cipoloti, L., Puel, M., Demonet, J. F., Chollet, F., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20653 · Cited by 161
Molecular Mimicry, Microbial Infection, and Autoimmune Disease: Evolution of the Concept
Oldstone, M. B. A. (2005) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-30791-5_1 · Cited by 146 · cited 1×
“If, however, the trigger acts in a 'hit-and-run' even”
Backgroundβ-Amyloid-induced Dynamin 1 Depletion in Hippocampal Neurons
Kelly, B. L., Vassar, R. J., & Ferreira, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503259200 · Cited by 145
Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals
Honer, W. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.005 · Cited by 135
The role of nicotinic acetylcholine receptors in Alzheimer’s disease
Oddo, S., & LaFerla, F. M. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.080 · Cited by 132
Tau and src family tyrosine kinases
Lee, G. S. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.002 · Cited by 130
Mark, R. J., Ashford, J. W., Goodman, Y., & Mattson, M. P. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00150-2 · Cited by 122
Increased seizure threshold and severity in young transgenic CRND8 mice
Vecchio, R. A. D., Gold, L. H., Novick, S. J., Wong, G., & Hyde, L. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.107 · Cited by 115
Prospects for Neurology and Psychiatry
Cowan, W. M., & Kandel, E. R. (2001) · JAMA · doi:10.1001/jama.285.5.594 · Cited by 111
Cotman, C. W., Hailer, N. P., Pfister, K. K., Soltész, I., & Schachner, M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00025-2 · Cited by 102
Can Alzheimer’s Disease and Dementias with Lewy Bodies be Distinguished Clinically?
Weiner, M., Hynan, L. S., Parikh, B., Zaki, N., White, C. L., Bigio, E. H., Lipton, A. M., Martin‐Cook, K., Svetlik, D. A., Cullum, C. M., et al. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988703258671 · Cited by 85
Functional Neurochemistry of Alzheimers Disease
Gsell, W., Jungkunz, G., & Riederer, P. F. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043386473 · Cited by 71
Calcium-Regulated Signaling Pathways: Role in Amyloid β-Induced Synaptic Dysfunction
Xie, C.-W. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:6:1:053 · Cited by 69
van Dellen, A., Grote, H., & Hannan, A. J. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04313.x · Cited by 65
Haddad, J. J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.06.002 · Cited by 64
Impaired Cross-Modal Inhibition in Alzheimer Disease
Drzezga, A. E., Grimmer, T., Peller, M., Wermke, M., Siebner, H. R., Rauschecker, J. P., Schwaiger, M., & Kurz, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020288 · Cited by 60
Antipsychotic Drug-Induced Movement Disorders
Blanchet, P. J. (2003) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100003309 · Cited by 56
Pharmaceutical, cellular and genetic therapies for Huntington's disease
Handley, O., Naji, J. J., Dunnett, S. B., & Rosser, A. (2005) · Clinical Science · doi:10.1042/cs20050148 · Cited by 55
Antibasal ganglia antibodies and their relevance to movement disorders
Martino, D., & Giovannoni, G. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137532.76491.19 · Cited by 43
Trapp, B., Hd, W., Johnson, D., Rh, Q., Cohen, S., & Murray, M. R. (1982) · Journal of Neuroscience · doi:10.1523/jneurosci.02-07-00986.1982 · Cited by 41
Do acetylcholinesterase inhibitors boost synaptic scaling in Alzheimer's disease?
Small, D. H. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.03.006 · Cited by 37
Synaptic mechanisms of the cerebellar cortical network
Nakanishi, S. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.12.004 · Cited by 37
Is there a role of the cyclin-dependent kinase 5 activator p25 in Alzheimer's disease?
Giese, K.-P., Ris, L., & Plattner, F. (2005) · Neuroreport · doi:10.1097/01.wnr.0000185019.67434.d2 · Cited by 33
Schmitt, H. P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2110-5 · Cited by 13
Inhibitory neuronal activity can compensate for adverse effects of β-amyloid in hippocampal neurons
Graf, R. A., & Kater, S. B. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01451-0 · Cited by 9
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Research works printed but not linked: 2
- Robertsson, B., Blennow, K., Gottfries, C. G. & Wallin, A. Delirium in dementia. Int. J. Geriatr. Psychiatry 13, 49–56 (1998). · doi:10.1002/(sici)1099-1166(199801)13:1<49::aid-gps733>3.0.co;2-4
- Kordower, J. H. et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 49, 202–213 (2001). · doi:10.1002/1531-8249(20010201)49:2<202::aid-ana40>3.0.co;2-3
Cited by
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350
“, 2007), some authors have suggested that neurodegeneration may relate to neural network dysfunction (Buckner et al., 2005; Palop et al., 2006).”
BackgroundReducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Self-citationAlzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
Self-citationThe connectomics of brain disorders
Fornito, A., Zalesky, A., & Breakspear, M. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3901 · Cited by 1,734
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Self-citation
Metadata
- Authors
- Palop, J. J., Chin, J., & Mucke, L.
- Venue
- Nature
- Published
- 2006-10
- Volume
- 443
- Issue
- 7113
- Pages
- 768-773
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2023986336
- Cited by
- 692
- References
- 100
- FWCI
- 11.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.